Sign In
Buy BDSX
$16.10
+0.660 (+4.27%)
At Close: Jun 03, 2026
Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript
01:06am, Friday, 10'th May 2024
Biodesix, Inc. (NASDAQ:BDSX ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Scott Hutton - CEO Robin Harper Cowie - CFO Chris Brinzey - IR Conference Call Participants A
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
06:21pm, Wednesday, 08'th May 2024
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.24 per share a year ago.
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
06:00am, Tuesday, 07'th May 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chie
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
06:00am, Wednesday, 24'th Apr 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release fi
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
05:00pm, Tuesday, 09'th Apr 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data was prese
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
07:17am, Friday, 05'th Apr 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,3
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
06:00am, Monday, 25'th Mar 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collabora
Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript
12:35pm, Friday, 01'st Mar 2024
Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
06:00am, Friday, 01'st Mar 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions and services company, today provided a corporate update and announced its fin
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
06:00am, Monday, 26'th Feb 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chie
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
06:00am, Friday, 16'th Feb 2024
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release finan
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
09:04am, Friday, 26'th Jan 2024
Despite the recent economic deceleration, positive factors like a tight labor market and strong consumer spending support a resilient U.S. economy. Goldman Sachs predicts increased state and local gov
3 Medical Services Stocks to Buy as Industry Trends Improve
11:16am, Friday, 24'th Nov 2023
The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, DOCS and BDSX are set to gain the most.
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
06:00am, Tuesday, 14'th Nov 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch
Biodesix, Inc. (BDSX) Q3 2023 Earnings Call Transcript
01:24pm, Saturday, 11'th Nov 2023
Biodesix, Inc. (NASDAQ:BDSX ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper C
